Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 11/20 | 0.59 |
| ▸ | FAAH | O00519 | 4/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.58 |
| ▸ | MEN1 | O00255 | 3/20 | 0.58 |
| ▸ | HSP90AA1 | P07900 | 4/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.54 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.54 |
| ▸ | CCR6 | P51684 | 2/20 | 0.54 |
| ▸ | MAPT | P10636 | 2/20 | 0.54 |
| ▸ | G6PD | P11413 | 2/20 | 0.54 |
| ▸ | PKM | P14618 | 1/20 | 0.54 |
| ▸ | HPGD | P15428 | 1/20 | 0.54 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.54 |
| ▸ | GAA | P10253 | 1/20 | 0.51 |
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | NPC1 | O15118 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | CASP1 | P29466 | 1/20 | 0.50 |
| ▸ | RAB9A | P51151 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30435094 | 1.00 | MGLL (0.59) | MGLLFAAHKMT2AMEN1HSP90AA1 | |
| SCHEMBL22399177 | 0.85 | MGLL (0.57) | MGLLFAAHKMT2AMEN1HSP90AA1 | |
| SCHEMBL29898506 | 0.83 | TLR9 (0.61) | MGLLFAAHHSP90AA1NPSR1CCR6 | |
| SCHEMBL1741609 | 0.83 | TLR9 (0.61) | MGLLFAAHHSP90AA1NPSR1CCR6 | |
| SCHEMBL94095 | 0.83 | MGLL (0.57) | MGLLFAAHHSP90AA1NPSR1CCR6 | |
| SCHEMBL13405900 | 0.82 | KMT2A (0.62) | KMT2AMEN1ALDH1A1NPSR1MAPT | |
| SCHEMBL21495979 | 0.82 | MGLL (0.53) | MGLLFAAHHSP90AA1ALDH1A1NPSR1 | |
| SCHEMBL8005849 | 0.82 | PKM (0.58) | MGLLFAAHKMT2AMEN1HSP90AA1 | |
| SCHEMBL30198527 | 0.82 | PKM (0.58) | MGLLFAAHKMT2AMEN1HSP90AA1 | |
| SCHEMBL3180754 | 0.82 | TSHR (0.54) | MGLLFAAHHSP90AA1NPSR1CCR6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112358479-B | Synthesis method of pyrrolo [3,4-c ] quinoline-1, 3-dione compound | 西北师范大学 | 2023-06-16 | — | — | CN | disclosed |
| CN-113307995-B | Temperature-resistant thermoplastic polyurethane film and preparation method thereof | 苏州市雄林新材料科技有限公司 | 2023-04-14 | — | — | CN | disclosed |
| CN-109971130-B | Cyanate ester resin composition and use thereof | 广东生益科技股份有限公司 | 2021-12-17 | — | — | CN | disclosed |
| CN-112358479-A | Synthesis method of pyrrolo [3,4-c ] quinoline-1, 3-diketone compound | 西北师范大学 | 2021-02-12 | — | — | CN | disclosed |
| US-20130025495-A1 | COMPOSITIONS COMPRISING A REACTIVE MONOMER AND USES THEREOF | ISP INVESTMENTS INC. (US) | 2013-01-31 | — | — | US | disclosed |
| US-20130025495-A1 | COMPOSITIONS COMPRISING A REACTIVE MONOMER AND USES THEREOF | ISP INVESTMENTS INC. (US) | 2013-01-31 | — | — | US | disclosed |
| EP-2467694-A1 | USE OF A BIS-MALEIC ANHYDRIDE CROSS-LINKING AGENT FOR FIXATION OF A CELL OR TISSUE SAMPLE | Roche Diagnostics GmbH (DE) | 2012-06-27 | — | — | EP | disclosed |
| WO-2011020612-A1 | USE OF A BIS-MALEIC ANHYDRIDE CROSS-LINKING AGENT FOR FIXATION OF A CELL OR TISSUE SAMPLE | ROCHE DIAGNOSTICS GMBH (DE) | 2011-02-24 | — | — | WO | disclosed |
| US-5314950-A | Molding materials, colorfastness, compatibility with acrylonitrile-styrene resins | CYTEC TECHNOLOGY CORP. (US) | 1994-05-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130025495-A1 | COMPOSITIONS COMPRISING A REACTIVE MONOMER AND USES THEREOF | MEP1A, MACF1, CYP1B1 | MGLL 1404/4885FAAH 2247/4885KMT2A 2245/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.